Table 2 Development of non-AIDS-defining cancers (NADCs) in patients with HIV infection (N = 1001)
From: Increased risk of non-AIDS-defining cancers in Asian HIV-infected patients: a long-term cohort study
Development of NADCs | 61 (6.1%) |
Development of gastrointestinal NADCs | 31 (3.1%) |
Median follow-up period (IQR), years | 9.0 (4.8–13.2) |
Stage at the time of NADC diagnosisa | |
 0 or I | 14 (22.9%) |
 II | 17 (27.9%) |
 III | 9 (14.8%) |
 IV | 21 (34.4%) |
Age at the time of NADC diagnosisa, years | |
 Median age (IQR) | 57 (49–65) |
 20–39 | 5 (8.2%) |
 40–59 | 31 (50.8%) |
 60–79 | 23 (37.7%) |
 80–89 | 2 (3.3%) |
 Antiretroviral therapy at the time of NADC diagnosisa | 61 (100%) |